Paper16211237
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
Fritz G. Int J Oncol, 2005. Cited by 69 papers, by iCite.
Cite this record
ConductScience Library. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). Papers, record 16211237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16211237
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Neoplasms | Major topic |
| Cell Adhesion | |
| Cell Death | |
| Cell Proliferation | |
| Humans | |
| Neoplasm Metastasis | |
| Radiation, Ionizing | |
| ras GTPase-Activating Proteins | |
| rho GTP-Binding Proteins |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42495630 | RHOA at the intersection of inflammation-driven and sporadic colorectal cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42495630 | PubMed |
| 39941069 | Statins as Secondary Preventive Agent to Limit Breast Cancer Metastatic Outgrowth. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39941069 | PubMed |
| 39000261 | Disulfidptosis: A Novel Prognostic Criterion and Potential Treatment Strategy for Diffuse Large B-Cell Lymphoma (DLBCL). | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000261 | PubMed |
| 38380861 | Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP. | Leuk Lymphoma | 2024 | https://conductscience.org/library/papers/38380861 | PubMed |
| 34460030 | Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study. | Breast Cancer Res Treat | 2021 | https://conductscience.org/library/papers/34460030 | PubMed |
| 34303383 | Statins: a repurposed drug to fight cancer. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34303383 | PubMed |
| 34001921 | Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes. | Sci Rep | 2021 | https://conductscience.org/library/papers/34001921 | PubMed |
| 33755739 | Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats. | Naunyn Schmiedebergs Arch Pharmacol | 2021 | https://conductscience.org/library/papers/33755739 | PubMed |
| 32927022 | Pleiotropic effects of statins: A focus on cancer. | Biochim Biophys Acta Mol Basis Dis | 2020 | https://conductscience.org/library/papers/32927022 | PubMed |
| 32046107 | Inverse Association between Statin Use and Stomach Cancer Incidence in Individuals with Hypercholesterolemia, from the 2002-2015 NHIS-HEALS Data. | Int J Environ Res Public Health | 2020 | https://conductscience.org/library/papers/32046107 | PubMed |
| 30895533 | Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes. | Breast Cancer Res Treat | 2019 | https://conductscience.org/library/papers/30895533 | PubMed |
| 28796249 | Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28796249 | PubMed |
| 28481295 | Inhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ Expression. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28481295 | PubMed |
| 28003840 | Lovastatin prevents bleomycin-induced DNA damage to HepG2 cells. | Res Pharm Sci | 2016 | https://conductscience.org/library/papers/28003840 | PubMed |
| 27051303 | Statin use and mortality of patients with prostate cancer: a meta-analysis. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/27051303 | PubMed |
| 23748751 | Statins are associated with reduced risk of gastric cancer: a meta-analysis. | Eur J Clin Pharmacol | 2013 | https://conductscience.org/library/papers/23748751 | PubMed |
| 22966225 | The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination. | PPAR Res | 2012 | https://conductscience.org/library/papers/22966225 | PubMed |
| 22621227 | Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model. | Curr Neurovasc Res | 2012 | https://conductscience.org/library/papers/22621227 | PubMed |
| 19787197 | Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins. | Int J Mol Med | 2009 | https://conductscience.org/library/papers/19787197 | PubMed |
| 19520495 | Molecular mechanisms involved in farnesol-induced apoptosis. | Cancer Lett | 2010 | https://conductscience.org/library/papers/19520495 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16211237
GET https://conductscience.org/api/papers/v1/16211237/cited_by?page=2